By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday a 2 percent increase in its third-quarter revenues year over year, falling short of analysts' consensus estimate.

The Hercules, Calif.-based life sciences and diagnostics products firm brought in total revenues of $471.5 million for the three months ended Sept. 30, compared to revenues of $461.1 million for the third quarter of 2009. Analysts had expected revenues of $476.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.